Medelis is a full service oncology clinical research company. We provide sponsors with a highly-skilled and proactive oncology clinical trial management team to design and manage phase I through phase III oncology trials in North America and Europe.
Our clinical team has deep oncology clinical experience, providing you with an extensive array of oncology resources to support your drug in the clinic. Our efficient and effective clinical team can streamline your trial planning, start-up, monitoring and management to deliver the data you need, in a quick and cost-effective manner.
For our clients, our services not only help to speed a drug to market; they also provide the decision support to optimize the financial results from your oncology drug development efforts.
It’s about making the right decisions, supporting your needs, and providing streamlined trial planning and management to get you the results you need.
Medelis acts as a partner by your side, unlike the big CRO approach. Relationships are our #1 priority. For our clients, this means more than completing your trial on time and on budget.
Read MoreFounded in 2003 by a group of experienced clinical research oncologists including Dan Von Hoff and Michael Gordon, we deliver oncology expertise at both the strategic and operational level.
Read MoreMedelis is led by a team with extensive experience in clinical operations and managing clinical studies, with deep experience building and growing both large and small CROs.
Read MoreMedelis is accustomed to working closely with other cutting-edge organizations in their respective fields. With this model, no single group is deviating from its core competencies.
Read More